Back to shop

SANAQ® SL 004

0.00

Clear
-
+

Total:

Description

Indicated to aid processing during manufacture, enhance the stability and effectiveness during manufacturing product process. Mixtures with high compressibility, superior diluition properties and fast disintegrating time. The purpose of the excipient is to aid processing during manufacture, enhance stability or bioavailability.

Main Application

Co-Processed excipent based on mix of Lactose monohydrate and Starch. It is designed for direct compression providing help to improve tablet hardness, faster disintegration, and superior flowability. Disintegration of the tablets is independent from tablet hardness and lubricant level.

Flow properties

SANAQ SL 004® shows excellent and superior free powder flow compared with physical mixture in same ratio of components showing very poor flow properties.

PSD

SANAQ® SL 004 has an average PSD of 300 – 550 microns.

Additional information

Manufacturer

Pharmatrans SANAQ

Quality

EP, JP, USP

Cas-No

64044-51-5, 9005-25-8

Composition

lactose, Starch

Function

Co-Processed

Compendial Name

Lactose Monohydrate (USP) / Maize Starch (USP)

Documents and Links

Sanaq SL_004_Specifications

Download

You may also like…

SSG SANAQ®

0.00
Pharmatrans SANAQ Select options